Karyopharm Therapeutics Inc.
KPTI
Revenue
34.08M
▼-9.97M▼-22.63%
3 Months ChangeAssets
108.42M
▲12.18M▲12.66%
3 Months ChangeLiabilities
401.34M
▲35.85M▲9.81%
3 Months ChangeFree Cash Flow
-38.98M
▲4.94M▲11.24%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-03
Form 8-K
ID: 0001503802-26-000006
2026-02-19
Form 8-K
ID: 0001193125-26-059349
2026-02-12
Form 8-K
ID: 0001193125-26-047670
2026-01-12
Form 8-K
ID: 0001193125-26-009738
2025-11-03
Form 10-Q
ID: 0001193125-25-261667
2025-11-03
Form 8-K
ID: 0001193125-25-261663
2025-10-14
Form 8-K
ID: 0001193125-25-239015
2025-10-08
Form 8-K
ID: 0001193125-25-233983
2025-09-11
Form 8-K
ID: 0001503802-25-000006
2025-08-11
Form 10-Q
ID: 0000950170-25-106238